Gonzalez-Ortiz, Fernando http://orcid.org/0000-0001-7897-9456
Kirsebom, Bjørn-Eivind
Contador, José http://orcid.org/0000-0002-9692-1570
Tanley, Jordan E.
Selnes, Per
Gísladóttir, Berglind
Pålhaugen, Lene
Suhr Hemminghyth, Mathilde
Jarholm, Jonas
Skogseth, Ragnhild
Bråthen, Geir http://orcid.org/0000-0003-3224-7983
Grøndtvedt, Gøril
Bjørnerud, Atle
Tecelao, Sandra
Waterloo, Knut
Aarsland, Dag
Fernández-Lebrero, Aida
García-Escobar, Greta
Navalpotro-Gómez, Irene
Turton, Michael
Hesthamar, Agnes
Kac, Przemyslaw R. http://orcid.org/0000-0001-5083-0924
Nilsson, Johanna http://orcid.org/0000-0002-2856-6060
Luchsinger, Jose
Hayden, Kathleen M. http://orcid.org/0000-0002-7745-3513
Harrison, Peter
Puig-Pijoan, Albert http://orcid.org/0000-0002-9848-3711
Zetterberg, Henrik http://orcid.org/0000-0003-3930-4354
Hughes, Timothy M.
Suárez-Calvet, Marc http://orcid.org/0000-0002-2993-569X
Karikari, Thomas K. http://orcid.org/0000-0003-1422-4358
Fladby, Tormod http://orcid.org/0000-0002-9984-9797
Blennow, Kaj http://orcid.org/0000-0002-1890-4193
Article History
Received: 9 August 2023
Accepted: 26 March 2024
First Online: 4 April 2024
Competing interests
: M.T. and P.H. are employees of Bioventix Plc. H.Z. has served at scientific advisory boards and/or as a consultant for Abbvie, Alector, Annexon, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Pinteon Therapeutics, Red Abbey Labs, Passage Bio, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, and has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche. K.B. has served as a consultant and at advisory boards for Acumen, ALZPath, BioArctic, Biogen, Eisai, Lilly, Moleac Pte. Ltd, Novartis, Ono Pharma, Prothena, Roche Diagnostics, and Siemens Healthineers; has served at data monitoring committees for Julius Clinical and Novartis; has given lectures, produced educational materials and participated in educational programs for AC Immune, Biogen, BioArctic, Celdara Medical, Eisai and Roche Diagnostics. H.Z. and K.B. are co-founders of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg. M.S.C. has served as a consultant and at advisory boards for Roche Diagnostics International Ltd and Grifols S.L., has given lectures in symposia sponsored by Roche Diagnostics, S.L.U. and Roche Farma, S.A., and was granted with a project funded by Roche Diagnostics International Ltd; payments were made to the institution (BBRC). A.P.P. has served on advisory boards for Schwabe Farma Iberica. T.K.K. has received honoraria from the University of Wisconsin Madison and the University of Pennsylvania and has an awarded patent (#WO2020193500A1), all unrelated to this work. B.E.K. has served as a consultant for Biogen and advisory board for Eisai. T.F. has served as a consultant and at the advisory boards for Biogen, Novo Nordisk, Eli Lilly, and Roche. The other authors declare no competing interest.